Endothelin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR;

CARDIOVASCULAR DISEASE; HORMONE RECEPTOR INTERACTION; HUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE;

EID: 0041808692     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00249.2003     Document Type: Review

References (56)

1. Alexander BT, Cockrell KL, Rinewalt AN, Herrington JN, and Granger JP. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 280: R1388-R1392, 2001.
2. Alexander BT, Rinewalt AN, Cockrell KL, Bennett WA, and Granger JP. Endothelin-A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37: 485-489, 2001.
3. Ballew JR and Fink GD. Role of ETA receptors in experimental ANG II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol 281: R150-R154, 2001.
4. Barton M, Shaw S, d'Uscio LV, Moreau P, and Luscher TF. Differential modulation of the renal and myocardial endothelin system by angiotensin II in vivo. J Cardiovasc Pharmacol 31: S265-S268, 1998.
5. Barton M, Shaw S, d'Uscio LV, Moreau P, and Luscher TF. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 238: 861-865, 1997.
6. Boemke W, Hocher B, Schleyer N, Krebs MO, and Kaczmarczyk G. Hemodynamic, renal, and endocrine responses to acute ETA blockade at different ANG II plasma levels. Am J Physiol Regul Integr Comp Physiol 280: R1322-R1331, 2001.
7. D'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, and Luscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 29: 435-441, 1997.
8. Dean R, Zhuo J, Alcorn D, Casley D, and Mendelson FAO. Cellular localization of endothelin receptor subtypes in the rat kidney following in vitro labeling. Clin Exp Pharmacol Physiol 23: 524-531, 1996.
9. Deng LY, Day R, and Schiffrin EL. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats. J Am Soc Nephrol 7: 1158-1164, 1996.
10. Di Nunzio AS, Jaureguiberry MS, Rodano V, Bianciotti LG, and Vatta MS. Endothelin-1 and -3 diminish neuronal NE release through an NO mechanism in rat anterior hypothalamus. Am J Physiol Regul Integr Comp Physiol 283: R615-R622, 2002.
11. Docherty CC, Kalmar-Nagy J, Engelen M, and Nathanielsz PW. Development of fetal vascular responses to endothelin-1 and acetylcholine in the sheep. Am J Physiol Regul Integr Comp Physiol 280: R554-R562, 2001.
12. Docherty CC, Kalmar-Nagy J, Engelen M, Koenen SV, Nijland M, Kuc RE, Davenport AP, and Nathanielsz PW. Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 281: R261-R268, 2001.
13. Gandley RE, Conrad KP, and McLaughlin MK. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regul Integr Comp Physiol 280: R1-R7, 2001.
14. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, and Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000.
15. Gariepy CE, Cass DT, and Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93: 867-872, 1996.
16. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, Fujii N, Miyazaki H, Matsuda M, and Yamaguchi I. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281: R2029-R2036, 2001.
17. Jones CR, Hiley CR, Pelton JT, and Miller RC. Autoradiographic localization of endothelin binding sites in kidney. Eur J Pharmacol 163: 379-382, 1989.
18. Karet FE, Kuc RE, and Davenport AP. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int 44: 36-42, 1993.
19. Kassab S, Novak J, Miller T, Kirchner K, and Granger J. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension. Hypertension 30: 682-686, 1997.
20. Kassab S, Miller M, Novak J, Reckelhoff J, Clower B, and Granger JP. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 31: 397-402, 1998.
21. Khalil RA and Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283: R29-R45, 2002.
22. Kohan D. Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26, 1997.
23. Kohzuki M, Johnston CI, Chai SY, Casley DJ, and Mendelsohn FAO. Localization and endothelin receptors in the rat kidney. Eur J Pharmacol 160: 193-194, 1989.
24. Koseki C, Imai M, Hirata Y, Yanagisawa M, and Masaki T. Binding sites for endothelin-1 in rat tissues: an autoradiographic study (Abstract). J Cardiovasc Pharmacol 13, Suppl 5: S153-S154, 1989.
25. Liu JL, Pliquett RU, Brewer E, Cornish KG, Shen YT, and Zucker IH. Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure. Am J Physiol Regul Integr Comp Physiol 280: R1906-R1913, 2001.
26. Michel H, Backer A, Meyer-Lehnert H, Migas I, and Kramer H. Rat renal, aortic and pulmonary endothelin-1 receptors: effects of changes in sodium and water intake. Clin Sci (Colch) 85: 593-597, 1993.
27. Miller DS, Masereeuw R, and Karnaky KJ Jr. Regulation of MRP2-mediated transport in shark rectal salt gland tubules. Am J Physiol Regul Integr Comp Physiol 282: R774-R781, 2002.
28. Mills TM, Pollock DM, Lewis RW, Branam HS, and Wingard CJ. Endothelin-1-induced vasoconstriction is inhibited during erection in rats. Am J Physiol Regul Integr Comp Physiol 281: R476-R483, 2001.
29. Molnar J, Nijland MJ, Howe DC, and Nathanielsz PW. Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 075, and 08 gestation in sheep. Am J Physiol Regul Integr Comp Physiol 283: R561-R567, 2002.
30. Moser L, Faulhaber J, Wiesner RJ, and Ehmke H. Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle. Am J Physiol Regul Integr Comp Physiol 282: R1389-R1394, 2002.
31. Nambi P, Pullen M, Wu HL, Aiyar N, Ohlstein EH, and Edwards RM. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131: 1081-1086, 1992.
32. Novak J, Danielson LA, Kerchner LJ, Sherwood OD, Ramirez RJ, Moalli PA, and Conrad KP. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 107: 1469-1475, 2001.
33. Novak J, Ramirez RJ, Gandley RE, Sherwood OD, and Conrad KP. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol Regul Integr Comp Physiol 283: R349-R355, 2002.
34. Ohuchi T, Kuwaki T, Ling G, Dweit D, Ju K, Onodera M, Cao W, Yanagisawa M, and Kumada M. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice. Am J Physiol Regul Integr Comp Physiol 276: R1071-R1077, 1999.
35. Pang CY, Xu H, Huang N, Forrest CR, Perreault TM, and Neligan PC. Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin. Am J Physiol Regul Integr Comp Physiol 280: R713-R720, 2001.
36. Peterson TV, Emmeluth C, and Bie P. Renal effects of nitric oxide synthase inhibition in conscious water-loaded dogs. Am J Physiol Regul Integr Comp Physiol 281: R584-R590, 2001.
37. Piuhola J, Hammes A, Schuh K, Neyses L, Vuolteenaho O, and Ruskoaho H. Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1. Am J Physiol Regul Integr Comp Physiol 281: R699-R705, 2001.
38. Platzack B, Wang Y, Crossley D, Lance V, Hicks JW, and Conlon JM. Characterization and cardiovascular actions of endothelin-1 and endothelin-3 from the American alligator. Am J Physiol Regul Integr Comp Physiol 282: R594-R602, 2002.
39. Pollock DM and Pollock JS. Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281: F144-F150, 2001.
40. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, and Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 30: 29-34, 1997.
41. Reckelhoff JF and Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
42. Sandgaard NC, Andersen JL, Holstein-Rathlou NH, and Bie P. Aortic blood flow subtraction: an alternative method for measuring total renal blood flow in conscious dogs. Am J Physiol Regul Integr Comp Physiol 282: R1528-R1535, 2002.
43. Sasser JM, Pollock JS, and Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 283: R243-R248, 2002.
44. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 25: 1135-1143, 1995.
45. Simonson MS and Dunn MJ. Endothelin peptides and the kidney. Annu Rev Physiol 55: 249-265, 1993.
46. Skott O and Carter AM. Relaxin is a vasodilator. Am J Physiol Regul Integr Comp Physiol 283: R347-R348, 2002.
47. Stocker SD, Stricker EM, and Sved AF. Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats. Am J Physiol Regul Integr Comp Physiol 280: R214-R224, 2001.
48. Suzuki T and Miyauchi T. A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes. Am J Physiol Regul Integr Comp Physiol 280: R1399-R1406, 2001.
49. Takemoto F, Uchida S, Ogata E, and Kurokawa K. Endothelin-1 and endothelin-3 binding to rat nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 264: F827-F832, 1993.
50. B receptor deficient rats. Am J Physiol Regul Integr Comp Physiol 284: R674-R681, 2003.
51. Ujiie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, and Marumo F. Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 90: 1043-1048, 1992.
52. Villamor E, Ruijtenbeek K, Pulgar V, De Mey JG, and Blanco CE. Vascular reactivity in intrapulmonary arteries of chicken embryos during transition to ex ovo life. Am J Physiol Regul Integr Comp Physiol 282: R917-R927, 2002.
53. Wilkes BM, Susin M, Mento PF, Maciaca CM, Girardi EP, Boss E, and Nord EP. Localization of endothelin-like immunoreactivity in rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 260: F913-F920, 1991.
54. Wilkins FC Jr, Alberola A, Mizelle HL, Opgenorth TJ, and Granger JP. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol Regul Integr Comp Physiol 268: R375-R381, 1995.
55. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki K, Goto Y, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
56. Yip AW and Krukoff TL. Endothelin-A receptors and NO mediate decrease in arterial pressure during recovery from restraint. Am J Physiol Regul Integr Comp Physiol 282: R881-R889, 2002.